XML 43 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 28, 2013
Jun. 29, 2012
Cash flow from operating activities:    
Net income $ 103,885 $ 103,237
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation expense 12,854 11,300
Amortization expense 79,095 57,875
Provision for doubtful accounts 261 1,486
Deferred income taxes (13,732) 381
Stock-based compensation 17,253 15,944
Income from equity method investments (11,414) (13,255)
Excess tax benefit for stock-based compensation (7,616) (15,254)
Provision for excess and obsolete inventories 569 4,993
Other non-cash items (494) (1,851)
Add decrease (increase) in assets:    
Accounts receivable (24,071) (38,589)
Other receivables (1,558) (6,638)
Inventories (14,725) 594
Other current and non-current assets (12,165) (8,904)
Add increase (decrease) in liabilities:    
Accounts payable (18,936) 4,148
Accrued compensation and benefits (7,166) 2,270
Deferred revenue 55,994 32,117
Accrued warranty expense (154) (1,814)
Other current and non-current liabilities 14,163 7,054
Net cash provided by operating activities 172,043 155,094
Cash flow from investing activities:    
Acquisitions of businesses, net of cash acquired (178,953) (337,676)
Acquisitions of property and equipment (39,431) (21,308)
Dividends received from equity method investments 2,526 221
Other 730 (706)
Net cash used in investing activities (215,128) (359,469)
Cash flow from financing activities:    
Issuances of common stock, net 23,954 27,162
Excess tax benefit for stock-based compensation 7,616 15,254
Proceeds from debt and revolving credit lines 239,613 436,500
Payments on debt and revolving credit lines (252,780) (304,013)
Net cash provided by financing activities 18,403 174,903
Effect of exchange rate changes on cash and cash equivalents (4,017) (3,212)
Net increase (decrease) in cash and cash equivalents (28,699) (32,684)
Cash and cash equivalents, beginning of period 157,771 154,621
Cash and cash equivalents, end of period $ 129,072 $ 121,937